Literature DB >> 30229908

New advances of lncRNAs in liver fibrosis, with specific focus on lncRNA-miRNA interactions.

Er-Bao Bian1,2, Zhi-Gang Xiong2,3, Jun Li2.   

Abstract

Noncoding RNAs (ncRNAs) were initially thought to be transcriptional byproducts. However, recent advances of ncRNAs research have increased our understanding of the importance of ncRNA in gene regulation and disease pathogenesis. Consistent with these developments, liver fibrosis research is also experiencing rapid growth in the investigation of links between ncRNAs and the pathology of this disease. The initial focus was on studying the function and regulation mechanisms of microRNAs (miRNAs). However, recently, elucidation of the mechanisms of long noncoding RNAs (lncRNAs) and lncRNA-mediated liver fibrosis has just commenced. In this review, we emphasize on abnormal expression of lncRNAs in liver fibrosis. Furthermore, we also discuss that the interaction of lncRNAs with miRNAs is involved in the regulation of the expression of protein-coding genes in liver fibrosis. Recent advances in understanding dysregulated lncRNAs expression and the lncRNAs-miRNAs interaction in liver fibrosis will help for developing new therapeutic targets and biomarkers of liver fibrosis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  liver fibrosis; lncRNA; microRNA; ncRNAs

Mesh:

Substances:

Year:  2018        PMID: 30229908     DOI: 10.1002/jcp.27069

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Role of Curcumin in Regulating Long Noncoding RNA Expression in Cancer.

Authors:  Abolfazl Amini; Parand Khadivar; Ali Ahmadnia; Morteza Alipour; Muhammed Majeed; Tannaz Jamialahmadi; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  BoT-Net: a lightweight bag of tricks-based neural network for efficient LncRNA-miRNA interaction prediction.

Authors:  Muhammad Nabeel Asim; Muhammad Ali Ibrahim; Christoph Zehe; Johan Trygg; Andreas Dengel; Sheraz Ahmed
Journal:  Interdiscip Sci       Date:  2022-08-10       Impact factor: 3.492

3.  LncRNA-6395 promotes myocardial ischemia-reperfusion injury in mice through increasing p53 pathway.

Authors:  Lin-Feng Zhan; Qi Zhang; Lu Zhao; Xue Dong; Xin-Yu Pei; Li-Li Peng; Xiao-Wen Zhang; Bo Meng; Wen-di Shang; Zhen-Wei Pan; Chao-Qian Xu; Yan-Jie Lu; Ming-Yu Zhang
Journal:  Acta Pharmacol Sin       Date:  2021-09-07       Impact factor: 7.169

4.  Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis.

Authors:  Xin Chen; Hai-Di Li; Fang-Tian Bu; Xiao-Feng Li; Yu Chen; Sai Zhu; Jia-Nan Wang; Si-Yu Chen; Ying-Yin Sun; Xue-Yin Pan; Na-Na Yin; Jie-Jie Xu; Cheng Huang; Jun Li
Journal:  Theranostics       Date:  2020-03-26       Impact factor: 11.556

5.  LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A.

Authors:  Xiaoxi Fan; Zhongwei Zhao; Jingjing Song; Dengke Zhang; Fazong Wu; Jianfei Tu; Min Xu; Jiansong Ji
Journal:  Cancer Cell Int       Date:  2021-03-04       Impact factor: 5.722

6.  LncRNA NORAD promotes bone marrow stem cell differentiation and proliferation by targeting miR-26a-5p in steroid-induced osteonecrosis of the femoral head.

Authors:  Dapeng Fu; Sheng Yang; Jianmin Lu; Haoyi Lian; Kairong Qin
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

7.  Long non‑coding RNA MBI‑52 inhibits the development of liver fibrosis by regulating the microRNA‑466g/SMAD4 signaling pathway.

Authors:  Yazhou Li; Peixiao Liu; Feipeng Wei
Journal:  Mol Med Rep       Date:  2021-12-01       Impact factor: 2.952

Review 8.  The Roles and Mechanisms of lncRNAs in Liver Fibrosis.

Authors:  Zhifa Wang; Xiaoke Yang; Siyu Gui; Fan Yang; Zhuo Cao; Rong Cheng; Xiaowei Xia; Chuanying Li
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.810

Review 9.  The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review).

Authors:  Yun Liu; Hongmei Sun; Bolat Makabel; Qingbin Cui; Jiajun Li; Chaoyue Su; Charles R Ashby; Zhesheng Chen; Jianye Zhang
Journal:  Oncol Rep       Date:  2019-05-03       Impact factor: 3.906

10.  Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.

Authors:  Kenji Takahashi; Yu Ota; Takayuki Kogure; Yuko Suzuki; Hidetaka Iwamoto; Keisuke Yamakita; Yohei Kitano; Satoshi Fujii; Masakazu Haneda; Tushar Patel; Tsuguhito Ota
Journal:  Cancer Sci       Date:  2019-12-05       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.